文献速递儿科与产科急症

建议妊娠期糖尿病孕妇在晚孕期挤奶(糖尿病与产前挤奶[DAME]):多中心、非盲、随机对照试验

Advising women with diabetes in pregnancy to express breastmilk in late pregnancy (Diabetes and Antenatal Milk Expressing [DAME]): a multicentre, unblinded, randomised controlled trial.
PubMed 文献 · Lancet · 2017-01-01
一句话结论对于并发症低风险的妊娠期糖尿病孕妇,从36周起每天挤奶两次不增加新生儿NICU入院率,作者认为无害。

这项在澳大利亚维多利亚州6家医院开展的多中心、两组、非盲随机对照试验纳入635例孕34–37周的单胎妊娠期或孕前糖尿病孕妇,1:1随机分为从36周起每日挤奶两次组(319例)与标准产科护理组(316例)。主要终点为新生儿NICU入院比例,两组无差异(挤奶组46/317[15%] vs 标准护理组44/315[14%];校正相对危险度1.06,95%CI 0.66–1.46)。挤奶组婴儿最常见严重不良事件为因呼吸支持入住NICU(3/317[<1%]),标准护理组为中度至重度脑病伴或不伴惊厥(3/315[<1%])。作者认为,建议并发症低风险的妊娠期糖尿病孕妇从36周起挤奶无害。

要点

  • 对于并发症低风险的妊娠期糖尿病孕妇,从36周起每日挤奶两次与标准护理相比,新生儿NICU入院比例无差异(15% vs 14%;校正RR 1.06,95%CI 0.66–1.46)。
  • 挤奶组婴儿最常见严重不良事件为因呼吸支持入住NICU(3/317[<1%]),标准护理组为中度至重度脑病伴或不伴惊厥(3/315[<1%])。
  • 作者结论:建议并发症低风险的妊娠期糖尿病孕妇从36周起挤奶无害。
  • 研究纳入孕34–37周单胎妊娠的孕前或妊娠期糖尿病孕妇,排除标准原文未报告。

适用人群与场景

  • 纳入孕34–37周、单胎妊娠、孕前或妊娠期糖尿病的孕妇,来自澳大利亚维多利亚州6家医院。

处置流程与药物剂量

  • 干预组从36周妊娠起每日挤奶两次(产前挤奶);对照组接受常规助产与产科护理,并辅以糖尿病教育者支持。

研究设计与关键结果

  • 多中心、两组、非盲随机对照试验,6家医院,纳入635例孕妇(挤奶组319例,标准护理组316例),主要分析排除3例后为挤奶组317例、标准护理组315例。
  • 主要终点新生儿NICU入院比例:挤奶组46/317(15%)vs 标准护理组44/315(14%),校正相对危险度1.06(95%CI 0.66–1.46)。
  • 挤奶组婴儿最常见严重不良事件为因呼吸支持入住NICU(3/317[<1%]);标准护理组为中度至重度脑病伴或不伴惊厥(3/315[<1%])。

证据类型、等级与局限

  • 证据类型:多中心、非盲、随机对照试验(RCT)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,对于并发症低风险的妊娠期糖尿病孕妇,建议从36周起挤奶无害。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Infants of women with diabetes in pregnancy are at increased risk of hypoglycaemia, admission to a neonatal intensive care unit (NICU), and not being exclusively breastfed. Many clinicians encourage women with diabetes in pregnancy to express and store breastmilk in late pregnancy, yet no evidence exists for this practice. We aimed to determine the safety and efficacy of antenatal expressing in women with diabetes in pregnancy.

METHODS: We did a multicentre, two-group, unblinded, randomised controlled trial in six hospitals in Victoria, Australia. We recruited women with pre-existing or gestational diabetes in a singleton pregnancy from 34 to 37 weeks' gestation and randomly assigned them (1:1) to either expressing breastmilk twice per day from 36 weeks' gestation (antenatal expressing) or standard care (usual midwifery and obstetric care, supplemented by support from a diabetes educator). Randomisation was done with a computerised random number generator in blocks of size two and four, and was stratified by site, parity, and diabetes type. Investigators were masked to block size but masking of caregivers was not possible. The primary outcome was the proportion of infants admitted to the NICU. We did the analyses by intention to treat; the data were obtained and analysed masked to group allocation. This trial is registered with the Australian New Zealand Clinical Trials Registry, number ACTRN12611000217909.

FINDINGS: Between June 6, 2011, and Oct 29, 2015, we recruited and randomly assigned 635 women: 319 to antenatal expressing and 316 to standard care. Three were not included in the primary analysis (one withdrawal from the standard care group, and one post-randomisation exclusion and one withdrawal from the antenatal expressing group). The proportion of infants admitted to the NICU did not differ between groups (46 [15%] of 317 assigned to antenatal expressing vs 44 [14%] of 315 assigned to standard care; adjusted relative risk 1·06, 95% CI 0·66 to 1·46). In the antenatal expressing group, the most common serious adverse event for infants was admission to the NICU for respiratory support (for three [<1%] of 317. In the standard care group, the most common serious adverse event for infants was moderate to severe encephalopathy with or without seizures (for three [<1%] of 315).

INTERPRETATION: There is no harm in advising women with diabetes in pregnancy at low risk of complications to express breastmilk from 36 weeks' gestation.

FUNDING: Australian National Health and Medical Research Council.

来源:Lancet,查看原文。版权归原作者所有。

参考来源

  1. Forster DA, Moorhead AM, Jacobs SE, et al. Advising women with diabetes in pregnancy to express breastmilk in late pregnancy (Diabetes and Antenatal Milk Expressing [DAME]): a multicentre, unblinded, randomised controlled trial. Lancet. 2017. PMID: 28589894. doi:10.1016/S0140-6736(17)31373-9

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。